 |
|
 |
|
Creation of a new mid-sized enterprise in Bavaria / Degussa to spin-off its NCN activities as AlzChem
Geschrieben am 25.09.2006 - [Nächster Artikel] |
|
|
Dusseldorf (ots) - Effective October 1, 2006 Degussa AG, Dusseldorf, will be placing the NCN business at its Trostberg and Schalchen sites in Bavaria, Germany, into a new legal entity known as AlzChem Trostberg GmbH. AlzChem will be a strong mid-sized player with clear regional roots.
Dr. Klaus Engel, Chairman of Degussa's Board of Management, on the decision: Our NCN activities operate in a difficult market and do not currently meet the profitability targets we have set ourselves as the world's leading specialty chemicals company. To give this business the necessary future prospects we are therefore transferring it to an independent legal entity. Given the commitment shown by everyone involved and, above all, the constructive role played by the representatives of the workforce and the German labor union IG BCE, I am optimistic about its future development.
The clear goal is to increase the flexibility of these operations and reduce costs through strict implementation of the structures of a mid-sized enterprise with a regional focus. To provide a sound basis for the future of these activities, Degussa has therefore initiated talks with representatives of the workforce on a solidarity pact, including a contribution by employees. AlzChem's objective is to align itself optimally to market requirements and increase its independence from Degussa's other activities.
AlzChem will be run by Stefan Greger (Managing Director Administration) and Dr. Joachim Semel (Managing Director Technology). Present employment contracts will be transferred to the new company.
NCN chemicals are products with typical nitrogen-carbon-nitrogen bonds. A whole range of new products in this class have been developed in Trostberg. The main applications are agriculture (e.g. crop protection, growth regulators and multi-purpose fertilizers), chemical products (e.g. pigments, pharmaceutical active substances and building blocks for chemical syntheses) and nutrition (e.g. creatine).
Degussa is the global market leader in specialty chemicals. Our business is creating essentials-innovative products and system solutions that make indispensable contributions to our customers' success. In fiscal 2005 around 44,000 employees worldwide generated sales of 11.8 billion euros and operating profits (EBIT) of 940 million euros.
Originaltext: Degussa AG digital press kits: http://presseportal.de/story.htx?firmaid=18754 press kits via RSS: feed://presseportal.de/rss/pm_18754.rss2 ISIN: DE0005421903
Contact: Hannelore Gantzer Spokeswoman Corporate Communications
T +49-211-65041-368 F +49-211-65041-527
hannelore.gantzer@ degussa.com
|
| |
 |
|
 |
| |
 |
Login |
 |
|
 |
Themen-Infos |
 |
|
 |
Artikel Bewertung |
 |
|
 |
durchschnittliche Punktzahl: 0 Stimmen: 0
|
|
 |
|